Motion sensors for monitoring physical activity in cystic fibrosis: what is the next step?

Physical Therapy Reviews

Volumn 15, Issue 3, 2010, Pages 197-203

  Bradley, Judy M ^a   Kent, Lisa ^a   Elborn, J Stuart ^b   O'Neill, Brenda ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

CYSTIC FIBROSIS; MOTION SENSORS; PHYSICAL ACTIVITY

Indexed keywords

EID: 84869507384     PISSN: 10833196     EISSN: 1743288X     Source Type: Journal    
DOI: 10.1179/1743288X10Y.0000000005     Document Type: Article

References (36)

1. Nixon PA, Orenstein DM, Kelsey SF, Doershuk CF. The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med 1992;327:1785–8.
2. Pianosi P, Le Blanc J, Almudevar A. Peak oxygen uptake and mortality in children with cystic fibrosis. Thorax 2005;60:50–4.
3. Troosters T, Langer D, Vrijsen B, Segers J, Wouters K, Janssens W, et al. Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis. Eur Respir J 2009;33:99–106.
4. Britto, MT, Garrett JM, Konrad TR, Majure JM, Leigh MW. Comparison of physical activity in adolescents with cystic fibrosis versus age-matched controls. Pediatr Pulmonol 2000;30:86–91.
5. Jolley CJ, Moxham J. A physiological model of patient-reported breathlessness during daily activities in COPD. Eur Respir Rev 2009;18:66–79.
6. Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Quantifying physical activity in daily life with questionnaires and motion sensors in COPD. Eur Respir J 2006;27:1040–55.
7. Patel SA, Benzo RP, Silvka WA, Sciurba FC. Activity monitoring and energy expenditure in COPD patients: a validation study. COPD 2007;4:107–12.
8. Moy ML, Garshick E, Matthess KR, Lew R, Reilly JJ. Accuracy of uniaxial accelerometer in chronic obstructive pulmonary disease. J Rehabil Res Dev 2008;45:611–8.
9. Garcia-Rio F, Lores V, Mediano, O, Rojo B, Hernanz A, Lopez-Collazo E, et al. Daily physical activity in patients with chronic obsructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 2009;180:506–12.
10. Pitta F, Takaki MY, de Oliviera NH, Sant’Anna TJ, Fontana AD, Kovelis D, et al. Relationship between pulmonary function and physical activity in daily life in patients with COPD. Respir Med 2008;102:1203–7.
11. Watz H, Waschki B, Meyer T, Magnussen H. Physical activity in patients with COPD. Eur Respir J 2009;33:262–72.
12. Hecht A, Ma S, Porszasz J, Casaburi R. Methodology for using long-term accelerometry monitoring to describe daily activity patterns in COPD. COPD 2009;6:121–9.
13. Dallas MI, McCusker C, Haggarty MC, Rochester CL, ZuWallack R. Using pedometers to monitor walking activity in outcome assessment for pulmonary rehabilitation. Chronic Respir Dis 2009;6(4):217–24.
14. Pitta F, Troosters T, Probst VS, Langer D, Decramer M, Gosselink R. Are patients with COPD more active after pulmonary rehabilitation? Chest 2008;134:273–80.
15. de Blok BMJ, de Greef MHG, ten Hacken NHT, Sprenger SR, Postema K, Wempe JB. The effects of a lifestyle physical activity counselling program with feedback of a pedometer during pulmonary rehabilitation in patients with COPD: a pilot study. Patient Educ Couns 2006;61:48–55.
16. Hospes G, Bossenbroek L, ten Hacken NH, van Hengel P, de Greef MH. Enhancement of daily physical activity increases physical fitness of outclinic COPD patients: results of an exericise counselling program. Patient Educ Couns 2009;75:274–8.
17. Troosters T, Sciurba F, Battaglia S, Langer D, Valluri SR, Martino L, et al. Physical inactivity in patients with COPD, a controlled multi-center pilot-study. Respir Med 2010; in press.
18. Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Physical activity and hospitalization for exacerbation of COPD. Chest 2006;129:536–44.
19. Döring G, Elborn JS, Johannesson M, de Jonge H, Griese M, Smyth A, et al. Clinical trials in cystic fibrosis. J Cyst Fibros 2007;6:85–99.
20. Food and Drug Administration. Guidance for industry E9: statistical principles for clinical trials. Silver Spring (MD): ICH/FDA; 1998.
21. European Medicines Agency & Committee for Medicinal Products for Human Use (EMEA CHMP). Guideline on the clinical development of medicinal products for the treatment of cystic fibrosis. London: EMEA CHMP; 2008.
22. Ramsey BW. Outcome measures for development of new therapies in cystic fibrosis: are we making progress and what are the next steps? Proc Am Thor Soc 2007;4:367–9.
23. Beghin L, Michaud L, Loeuille G-A, Wizla-Derambure N, Sayah H, Sardet A, et al. Changes in lung function in young cystic fibrosis patients between two courses of intravenous antibiotics against pseudomonas aeruginosa. Pediatr Pulmonol 2009;44:464–71.
24. Dwyer TJ, Alison JA, McKeough ZJ, Elkins MR, Bye PTP. Evaluation of the SenseWear activity monitor during exercise in cystic fibrosis and in health. Respir Med 2009;103:1511–7.
25. Wells GD, Wilkes D, Schneiderman-Walker J, Elmi M, Tullis E, Lands L, et al. Reliability and validity of the habitual activity estimation scale (HAES) in patients with cystic fibrosis. Pediatr Pulmonol 2008;43:345–53.
26. Hebestreit H, Kieser S, Rüdiger S, Schenk T, Junge S, Hebestreit A, et al. Physical activity is independently related to aerobic capacity in cystic fibrosis. Eur Respir J 2006;28: 734–9.
27. Janz KF, Cassady SL, Barr RN, Kelly JM. Monitoring exercise in children and adolescents with cyctic fibrosis: validation ofthe CSA accelerometer. Cardiopulm Phys Ther 1995;6(2): 3–8.
28. Selvadurai HC, Blimkie CJ, Cooper PJ, Mellis CM, van Asperen PP. Gender differences in habitual activity in children with cystic fibrosis. Arch Dis Child 2004;89:928–33.
29. Selvadurai HC, Blimkie CJ, Meyers N, Mellis CM, van Asperen PP. Randomized controlled study of in-hospital exercise training programs in children with cystic fibrosis. Pediatr Pulmonol 2002;33:194–200.
30. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171:972–7.
31. Moy ML, Matthess K, Stolzmann K, Reilly J, Garschick E. Free-living activity in COPD: Assessment with accelerometer and activity checklist. J Rehabil Res Dev 2009;46:277–86.
32. Schönhofer B, Ardes P, Geibel M, Köhler D, Jones PW. Evaluation of a movement detector to measure daily activity in patients with chronic lung disease. Eur Respir J 1997;10:2814–9.
33. Berman N, Bailey R, Barstow TJ, Cooper DM. Spectral and bout detection analysis of physical activity patterns in healthy, prepubertal boys and girls. Am J Human Biol 1998;10:289–97.
34. Hawkins MS, Storti KL, Richardson CR, King WC, Strath SJ, Holleman RG, et al. Objectively measured physical activity of USA adults by sex, age, and racial/ethnic groups: a crosssectional study. Int J Behav Nutr Phys Act 2009;6:31.
35. Freedson PS, Melanson E, Sirard J. Calibration of the Computer Science and Applications, Inc. accelerometer. Med Sci Sports Exerc 1998;30:777–81.
36. National Institute for Health and Clinical Excellence (NICE). Four commonly used methods to increase physical activity: brief inventions in primary care, exercise referral schemes, pedometers and community-based exercise programmes for walking and cycling. London: NICE; March 2006.